Le Lézard

Communiqués de presse par sujet : Essais cliniques / Découvertes médicales

1 2 3 4 5 6 7 8 9 10 11 12

11 octobre 2017

17:03
SAN DIEGO, Oct. 11, 2017 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (NASDAQ:ONCS), a company developing DNA-based intratumoral cancer immunotherapies, will present updated clinical data from its phase 2 Investigator Sponsored Trial...

16:02
FREMONT, Calif., Oct. 11, 2017 /PRNewswire/ -- Ardelyx, Inc. (NASDAQ: ARDX) today reported positive results from T3MPO-2, its second Phase 3 study of tenapanor for irritable bowel syndrome with constipation (IBS-C). The study hit statistical...

14:57
NORTH CHICAGO, Ill., Oct. 11, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global research and development based biopharmaceutical company, today announced that it will present new data evaluating MAVYRETtm (glecaprevir/pibrentasvir), its once-daily,...

14:51
NEW YORK, Oct. 11, 2017 /PRNewswire-USNewswire/ -- Mice born by Caesarian section gained on average 33 percent more weight in the 15 weeks after weaning than mice born vaginally, with females gaining 70 percent more weight. This is the finding of a...

11:44
ROTTERDAM, the Netherlands and LAGUNA HILLS, Calif., Oct. 11, 2017 /PRNewswire/ -- SkylineDx today announced that The Institute of Cancer Research, London (ICR) and University of Leeds will use MMprofilertm with SKY92, SkylineDx's prognostic tool to...

10:30
MENLO PARK, Calif., Oct. 11, 2017 /PRNewswire/ -- BioPharmX Corporation (NYSE MKT: BPMX) researchers were part of a national scientific team that developed an innovative way to use nonlinear optical imaging to confirm the efficiency and quantity of...

09:24
BOSTON and CAMBRIDGE, Mass., Oct. 11, 2017 /PRNewswire/ -- Biotech entrepreneur Kevin Hrusovsky will moderate an expert keynote panel discussion on brain health, including a deep dive into CTE and Concussions on Tuesday, October 24th, day one of...

09:00
MARIETTA, Ga., Oct. 11, 2017 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected...

08:44
HORSHAM, Pa., Oct. 11, 2017 /PRNewswire/ -- Janssen Biotech, Inc. today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for apalutamide, an investigational, next generation oral androgen...

08:35
RUTLAND, Mass., Oct. 11, 2017 /PRNewswire/ -- A brand new clinical trial database and collaborative platform was launched on the 3rd of October, with the aim of being the leading source for every clinical trial data need. PrimaryEndpoints.com will...

08:30
BARCELONA, Spain, October 11, 2017 /PRNewswire/ -- SOM Biotech (SOM), a leading drug repurposing company based in Barcelona, Spain, has determined and validated an entirely new usage for Nippon Chemiphar's marketed hypertension therapy bevantolol...

08:00
SAN DIEGO, Oct. 11, 2017 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc. (NASDAQ: MBVX), a clinical-stage biotechnology company focused on the development of antibody-based products to address unmet medical needs in the treatment of cancer, today...

08:00
SOUTH SAN FRANCISCO, Calif., Oct. 11, 2017 /PRNewswire/ -- Sutro Biopharma has received a manufacturing milestone payment from Celgene and has completed production of STRO-001, its first internally-developed antibody drug conjugate, or ADC, using...

08:00
MORTSEL, Belgium, October 11, 2017 /PRNewswire/ -- Health Imaging reaches the tipping point: more and more hospitals around the world are adopting an enterprise imaging approach: Recent study by Logicalis Healthcare Solutions lays out how...

07:00
SOUTH SAN FRANCISCO, Calif., Oct. 11, 2017 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeuratm long-term, continuous drug...

07:00
MOSCOW, October 11, 2017 /PRNewswire/ -- Young scientists from NUST MISIS have developed a material with which scientists and doctors can create durable and easy-to-implement bone, joint, and muscle replacements.      (Photo:...


10 octobre 2017

17:00
CHICAGO, Oct. 10, 2017 /PRNewswire/ -- Brain Research Foundation (BRF) will bestow its 2017 Frederic A. Gibbs award to a Chicago couple dedicated to the support and growth of innovative neuroscience research, and a financial company whose...

15:25
SAN FRANCISCO, Oct. 10, 2017 /PRNewswire/ -- Data from a prospective study on novel DotLab endometriosis biomarkers will be presented at the 2017 American Society of Reproductive Medicine (ASRM) Scientific Congress and Expo. The scientific abstract,...

14:10
SAN DIEGO, Oct. 10, 2017 /PRNewswire/ -- Biotheranostics today announced publication in the Clinical Cancer Research journal  of a study evaluating performance of a  Breast Cancer Index (BCI) that was specifically developed for early-stage, ER+...

13:59
-- Results from a 12-country survey of more than 75,000 patients shows limited patient awareness about cataract disease and available treatment options -- New findings presented at the XXXV European Society of Cataract & Refractive Surgeons (ESCRS)...

10:49
Study Shows Successful Delivery in Brain Cancer Patients and Reassuring Safety Profile TORONTO and HOUSTON, TX, Oct. 10, 2017 /PRNewswire/ - Medicenna Therapeutics Corp.  ("Medicenna" or "the Company") (TSX "MDNA"), a clinical stage...

10:24
LAS VEGAS, Oct. 10, 2017 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) has entered into a Contract Research Agreement with the Universidad de Sevilla ("USE") to develop a time-released version of GB Sciences' proprietary, THC-free, myrcene-based...

09:53
MINNETONKA, Minn., Oct. 10, 2017 /PRNewswire/ -- Respicardia, Inc., a private medical technology company, announced today that it received U.S. Food and Drug Administration (FDA) approval of its remed?® System, a transvenous implantable...

09:00
PRAGUE, October 10, 2017 /PRNewswire/ -- Treatment with Ped-PRM significantly improved total sleep time (TST), sleep initiation and maintenance  Parents' quality of life and satisfaction from children's sleep increased significantly  ...

08:37
SAN DIEGO, Oct. 10, 2017 /PRNewswire/ -- Abide Therapeutics, a developer of innovative pharmaceuticals, announced today initiation of dosing in a Phase 1b study to evaluate the effects of ABX-1431, a first-in-class investigational monoacylglycerol...

08:30
MADRID, October 10, 2017 /PRNewswire/ -- PharmaMar (MCE: PHM) will present the final efficacy and safety data obtained from the Phase I/II trial combining PM1183 (lurbinectedin) with doxorubicin in relapsed small-cell lung cancer during a 'Research...

08:30
NOVATO, California, TOKYO and LONDON, October 10, 2017 /PRNewswire/ -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, Kyowa Hakko Kirin Co.,...

08:00
SAN DIEGO, Oct. 10, 2017 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec" or the "Company") (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced that it has initiated its phase 2b registration directed...

08:00
EXTON, Pa., Oct. 10, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today shared the results of a study highlighting the benefits of West's ID Adapter...

08:00
TOKYO and BOTHELL, Wash., Oct. 10, 2017 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") and Seattle Genetics Inc., (NASDAQ: SGEN) today announced dosing of the first patient in EV-201, a...

07:46
Le docteur Achille Gaspardone a présenté le registre de données italiennes/suédoises pour le système d'occlusion de FOP à base de sutures HeartStitch ® FRANCFORT, Allemagne, 10 octobre 2017 /PRNewswire/ -- Le professeur Achille Gaspardone,...

07:30
LEXINGTON, Mass., Oct. 10, 2017 /PRNewswire/ -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) ("Aldeyra" or "the Company"), a clinical-stage biotechnology company devoted to treating inflammation, inborn errors of metabolism, and other diseases related...

07:01
NEW YORK, Oct. 10, 2017 /PRNewswire-USNewswire/ -- The National Multiple Sclerosis Society has committed nearly $14 million to support 40 new MS research projects. These are part of a comprehensive approach to accelerate research breakthroughs aimed...

07:00
KIRKLAND, QC, Oct. 10, 2017 /CNW/ - Ortho Regenerative Technologies Inc. ("Ortho RTi" or the "Corporation"), an emerging Orthopaedic and Sports Medicine Technology company, will begin trading today on the Canadian Securities Exchange ("CSE") under...

06:45
INDIANAPOLIS, Oct. 10, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that its Phase 3 JUNIPER study evaluating Verzeniotm (abemaciclib), a cyclin-dependent kinase (CDK)4 and CDK6 inhibitor, as monotherapy in KRAS-mutated,...

05:00
Dr. Achille Gaspardone Presented The Italian/Swedish Data Registry For HeartStitch ® 's PFO Suture Based Closure System FRANKFURT, Germany, Oct. 10, 2017 /PRNewswire/ -- Prof. Dr. Achille Gaspardone, Director of Cardiology at Hospital of...


9 octobre 2017

19:01
BASEL, Switzerland, October 10, 2017 /PRNewswire/ -- Mundipharma EDO GmbH (EDO) has begun a US Phase 1/2 clinical study for tinostamustine (EDO-S101) in patients with advanced solid tumors at Stanford University, Cedars Sinai Medical Center (Los...

16:56
NEW YORK, Oct. 9, 2017 /PRNewswire/ -- ThyroSeq®, a joint partnership between UPMC and CBLPath, announced today, that the results of a double-blind, multi-center international study, validating the performance of ThyroSeq V3® in thyroid nodules with...

16:05
HILDEN and ROSTOCK, Germany and GERMANTOWN, Maryland, October 9, 2017 /PRNewswire/ -- QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) and CENTOGENE AG today announced a collaboration and co-marketing agreement to provide customers more complete...

16:00
THOUSAND OAKS, Calif., Oct. 9, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Application (sBLA) for Prolia® (denosumab) for the...

15:31
ROME, Oct. 9, 2017 /PRNewswire/ -- Prof. Dr. Achille Gaspardone, Director of Cardiology at Hospital of Sant'Eugenio (Rome, Italy) presented a comprehensive report on closure of PFO (Patent Foramen Ovale) and related Atrial Septal Defect...

14:04
SANTA CLARA, Calif., Oct. 9, 2017 /PRNewswire/ -- Frost & Sullivan, the growth partnership company, announced today that it will host a live, complimentary Growth Innovation Leadership (GIL) briefing titled, "Microbiome: Revisiting the Micro and...

13:32
SANTA BARBARA, Calif., Oct. 9, 2017 /PRNewswire/ -- Evolus, Inc. (www.Evolus.com) today announced presentations of the data from the Phase II and III clinical trials of its investigational prabotulinumtoxinA 900 kilodalton (kDa) neuromodulator at The...

10:00
ELLICOTT CITY, Md., Oct. 9, 2017 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS) announced to over 900 attendees at its 2017 Global Site Solutions Summit that Eli Lilly is the winning sponsor of the 2017 Sponsor Eagle Award, and INC...

09:05
PALO ALTO, Calif., Oct. 9, 2017 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP) (AirXpanders or Company), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that...

08:30
DUBLIN, Oct. 9, 2017 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that positive new data from multiple studies of VIBATIV® (telavancin) were presented at IDWeektm 2017, which was...

08:30
BOCA RATON, Fla., Oct. 9, 2017 /PRNewswire/ -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and keloids with Superficial Radiation Therapy (SRT), announced today that an...

08:00
SAN DIEGO, Oct. 9, 2017 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) granted an orphan drug designation to PCM-075 for the treatment of...

08:00
EXTON, Pennsylvania, Oct. 9, 2017 /PRNewswire/ --Essential Medical, Inc. today announced initiation of enrollment in a post market clinical registry in the regions where MANTAtm is commercially available.  Principle...

08:00
SAN DIEGO, Oct. 9, 2017 /PRNewswire/ -- Amplyx Pharmaceuticals, a company developing novel antimicrobial agents for life-threatening fungal infections, today announced that it presented results from two Phase 1 studies of APX001, plus new nonclinical...

1 2 3 4 5 6 7 8 9 10 11 12